These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 30935497)
21. Between-center variability of results of the in vitro contracture test for malignant hyperthermia susceptibility. Ording H; Islander G; Bendixen D; Ranklev-Twetman E Anesth Analg; 2000 Aug; 91(2):452-7. PubMed ID: 10910867 [TBL] [Abstract][Full Text] [Related]
22. Anesthetic drugs and onset of malignant hyperthermia. Visoiu M; Young MC; Wieland K; Brandom BW Anesth Analg; 2014 Feb; 118(2):388-396. PubMed ID: 24445637 [TBL] [Abstract][Full Text] [Related]
24. The differential effect of halothane and 1,2-dichlorohexafluorocyclobutane on in vitro muscle contractures of patients susceptible to malignant hyperthermia. Kindler CH; Girard T; Gong D; Urwyler A Anesth Analg; 2002 Apr; 94(4):1028-33, table of contents. PubMed ID: 11916818 [TBL] [Abstract][Full Text] [Related]
25. Comparative analysis of in vitro contracture tests with ryanodine and a combination of ryanodine with either halothane or caffeine: a comparative investigation in malignant hyperthermia. Bendahan D; Guis S; Monnier N; Kozak-Ribbens G; Lunardi J; Ghattas B; Mattei JP; Cozzone PJ Acta Anaesthesiol Scand; 2004 Sep; 48(8):1019-27. PubMed ID: 15315621 [TBL] [Abstract][Full Text] [Related]
26. Multicentre evaluation of in vitro contracture testing with bolus administration of 4-chloro-m-cresol for diagnosis of malignant hyperthermia susceptibility. Wappler F; Anetseder M; Baur CP; Censier K; Doetsch S; Felleiter P; Fiege M; Fricker R; Halsall PJ; Hartung E; Heffron JJ; Heytens L; Hopkins PM; Klingler W; Lehmann-Horn F; Nivoche Y; Tegazzin V; Tzanova I; Urwyler A; Weisshorn R; Schulte am Esch J Eur J Anaesthesiol; 2003 Jul; 20(7):528-36. PubMed ID: 12884985 [TBL] [Abstract][Full Text] [Related]
27. Administration of anaesthetic triggering agents to patients tested malignant hyperthermia normal and their relatives in New Zealand: an update. Frei D; Stowell KM; Langton EE; McRedmond L; Pollock NA; Bulger TF Anaesth Intensive Care; 2017 Sep; 45(5):611-618. PubMed ID: 28911291 [TBL] [Abstract][Full Text] [Related]
31. The in vitro determination of susceptibility to malignant hyperthermia. Iaizzo PA; Lehmann-Horn F Muscle Nerve; 1989 Mar; 12(3):184-90. PubMed ID: 2725548 [TBL] [Abstract][Full Text] [Related]
32. Effect of cocaine on the contracture response to 1% halothane in patients undergoing diagnostic muscle biopsy for malignant hyperthermia. Sato N; Brum JM; Mitsumoto H; DeBoer GE Can J Anaesth; 1995 Feb; 42(2):158-62. PubMed ID: 7720160 [TBL] [Abstract][Full Text] [Related]
34. Results of contracture tests with halothane, caffeine, and ryanodine depend on different malignant hyperthermia-associated ryanodine receptor gene mutations. Fiege M; Wappler F; Weisshorn R; Ulrich Gerbershagen M; Steinfath M; Schulte Am Esch J Anesthesiology; 2002 Aug; 97(2):345-50. PubMed ID: 12151923 [TBL] [Abstract][Full Text] [Related]
35. Masseter muscle rigidity and malignant hyperthermia susceptibility in pediatric patients. An update on management and diagnosis. O'Flynn RP; Shutack JG; Rosenberg H; Fletcher JE Anesthesiology; 1994 Jun; 80(6):1228-33. PubMed ID: 8010468 [TBL] [Abstract][Full Text] [Related]
36. Porcine malignant hyperthermia: effects of temperature and extracellular calcium concentration on halothane-induced contracture of susceptible skeletal muscle. Nelson TE; Bedell DM; Jones EW Anesthesiology; 1975 Mar; 42(3):301-6. PubMed ID: 1115384 [TBL] [Abstract][Full Text] [Related]
37. Masseter spasm induced by succinylcholine in children: contracture testing for malignant hyperthermia: report of six cases. Flewellen EH; Nelson TE Can Anaesth Soc J; 1982 Jan; 29(1):42-9. PubMed ID: 7055743 [TBL] [Abstract][Full Text] [Related]
38. Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands. Riazi S; Larach MG; Hu C; Wijeysundera D; Massey C; Kraeva N Anesth Analg; 2014 Feb; 118(2):381-387. PubMed ID: 23842196 [TBL] [Abstract][Full Text] [Related]
39. [Effect of chlorocresol vs caffeine on muscle contracture in malignant hyperthermia susceptible patients]. Ben-Abraham R; Krivosic-Horber RM; Haudcoeur G; Perel A; Adnet PJ Harefuah; 1997 Jun; 132(12):839-41, 911. PubMed ID: 9264187 [TBL] [Abstract][Full Text] [Related]
40. The Israeli Diagnostic Center for Malignant Hyperthermia: 7-years' accumulated experience. Glauber V; Ben Abraham R; Zweig A; Perel A Isr J Med Sci; 1997 Oct; 33(10):643-7. PubMed ID: 9397136 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]